BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2554800)

  • 1. Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.
    Yang ZH; Lucia HL; Tolman RL; Colonno RJ; Hsiung GD
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1563-8. PubMed ID: 2554800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
    Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
    Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.
    Fong CK; Cohen SD; McCormick S; Hsiung GD
    Antiviral Res; 1987 Jan; 7(1):11-23. PubMed ID: 3026243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effect of oxetanocin G against guinea pig cytomegalovirus infection in vitro and in vivo.
    Yamamoto N; Yamada Y; Daikoku T; Nishiyama Y; Tsutsui Y; Shimada N; Takahashi K
    J Antibiot (Tokyo); 1990 Dec; 43(12):1573-8. PubMed ID: 2177463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of two acycleonucleoside derivatives on ultrastructure and replication of guinea pig cytomegalovirus in cultured cells.
    Yang ZH; Klein S; Hsiung GD
    Intervirology; 1991; 32(5):297-307. PubMed ID: 1657821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with 2'-nor-cGMP and ganciclovir against cytomegalovirus infection in a guinea pig model.
    Feng JS; Crouch JY; Tolman RL; Lucia HL; Hsiung GD
    Antiviral Res; 1992 Sep; 19(3):193-206. PubMed ID: 1332604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined antiviral effects of paired nucleosides against guinea pig cytomegalovirus replication in vitro.
    Yang ZH; Crouch JY; Feng JS; Chou TC; Hsiung GD
    Antiviral Res; 1990; 14(4-5):249-65. PubMed ID: 1965111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
    Bravo FJ; Cardin RD; Bernstein DI
    J Infect Dis; 2006 Feb; 193(4):591-7. PubMed ID: 16425139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.
    Stals FS; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2262-6. PubMed ID: 1666493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of two new antiviral agents against guinea pig lymphotropic herpesvirus infection in vitro.
    Hu JM; Hsiung GD
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1600-5. PubMed ID: 2817855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An animal model of neonatal cytomegalovirus infection.
    Bravo FJ; Bourne N; Schleiss MR; Bernstein DI
    Antiviral Res; 2003 Sep; 60(1):41-9. PubMed ID: 14516920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.
    Schleiss MR; Bernstein DI; McVoy MA; Stroup G; Bravo F; Creasy B; McGregor A; Henninger K; Hallenberger S
    Antiviral Res; 2005 Jan; 65(1):35-43. PubMed ID: 15652969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of S26308 against guinea pig cytomegalovirus infection.
    Chen M; Griffith BP; Lucia HL; Hsiung GD
    Antimicrob Agents Chemother; 1988 May; 32(5):678-83. PubMed ID: 2840014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.
    Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP
    J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals.
    Bourne N; Bravo FJ; Bernstein DI
    Antiviral Res; 2000 Aug; 47(2):103-9. PubMed ID: 10996398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.
    Bravo FJ; Bernstein DI; Beadle JR; Hostetler KY; Cardin RD
    Antimicrob Agents Chemother; 2011 Jan; 55(1):35-41. PubMed ID: 21078944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acyclovir and phosphonoformate on cytomegalovirus infection in guinea pigs.
    Lucia HL; Griffith BP; Hsiung GD
    Intervirology; 1984; 21(3):141-9. PubMed ID: 6327560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of guinea pig cytomegalovirus and guinea pig herpes-like virus: pathogenesis and persistence in experimentally infected animals.
    Tenser RB; Hsiung GD
    Infect Immun; 1976 Mar; 13(3):934-40. PubMed ID: 178599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of guinea pigs to intravaginal inoculation with guinea pig cytomegalovirus.
    Barron AL; Menna JH; Moses EB; Rank RG; Ryu H; White HJ
    Sex Transm Dis; 1989; 16(1):41-6. PubMed ID: 2547250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclosporine and cortisone on the pathogenesis of primary infection with cytomegalovirus in the guinea pig.
    MacGregor MP; Lucia HL; Vine W; FitzGerald P; Bia FJ
    J Infect Dis; 1986 Mar; 153(3):503-10. PubMed ID: 3005426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.